Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930

NCT05207761 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma

Interventions

DRUG: D565
DRUG: D930

Sponsor

Chong Kun Dang Pharmaceutical